Archives: ClinicianPOV

Factors Contributing to the Clinical Consequences of Polycythemia Vera

Michael J. Mauro, MD, is a board-certified hematologist and head of the myeloproliferative neoplasms program and leukemia service at Memorial Sloan Kettering Cancer Center, in New York City. His area of clinical focus includes treatment of chronic myeloid leukemia and myeloproliferative disorders, including polycythemia vera and thrombocytosis. Posted by Haymarket’s Clinical Content Hub. The editorial…